Chateau N, Castellanos I, Deschamps A M
Laboratoire de Microbiologie et de Biotechnologie, Institut des Sciences et Techniques des Aliments, Université Bordeaux I, Talence, France.
J Appl Bacteriol. 1993 Jan;74(1):36-40. doi: 10.1111/j.1365-2672.1993.tb02993.x.
Pure strains of Lactobacillus ssp. isolated from a commercial probiotic consortium were checked in a double layer solid medium for their inhibition activities against selected pathogenic bacteria including serotypes of Listeria monocytogenes, Escherichia coli and Salmonella. The antagonistic properties of the Lactobacillus strains may be related to the production of bacteriocin-like compounds. All the pathogens tested were inhibited by one or a few strains of Lactobacillus, the best inhibition was observed against L. monocytogenes but the inhibition was also satisfactory against E. coli, Salm. typhimurium and Salm. enteritidis.
从商业益生菌组合中分离出的纯乳酸杆菌菌株，在双层固体培养基中检测其对选定病原菌的抑制活性，这些病原菌包括单核细胞增生李斯特菌、大肠杆菌和沙门氏菌的血清型。乳酸杆菌菌株的拮抗特性可能与类细菌素化合物的产生有关。所有测试的病原体都被一种或几种乳酸杆菌菌株抑制，对单核细胞增生李斯特菌的抑制效果最佳，但对大肠杆菌、鼠伤寒沙门氏菌和肠炎沙门氏菌的抑制效果也令人满意。
